Global Uterine Polyps Drug Market, By Treatment (Medication, Surgery), Diagnosis (Transvaginal Ultrasound, Hysteroscopy, Endometrial Biopsy), Stages (Benign, Precancerous Polyps), Drugs Type (Levonorgestrel, Progesterone, Gonadotropin Releasing Hormone, Others), Route of Administration (Oral, Intravenous, Others), End- User (Hospitals, Homecare, Specialty Clinics, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028